Department of Neurosurgery, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114, USA.
Department of Otolaryngology, Massachusetts Eye and Ear, 243 Charles St., Boston, MA, 02114, USA.
J Clin Neurosci. 2024 Apr;122:93-102. doi: 10.1016/j.jocn.2024.03.001. Epub 2024 Mar 15.
Though the endoscopic endonasal approach (EEA) is a widely accepted treatment for skull base tumors, the specific use of EEA for olfactory groove meningiomas (OGMs) is debated, with variable outcomes reported in the literature. We review the surgical results of OGM resections for one surgeon including the operative approach, surgical nuances, and outcomes, with a focus on factors relating to patient selection which favor EEA over transcranial approaches.
We retrospectively reviewed thirteen cases of endoscopic endonasal resection of olfactory groove meningiomas. Patient characteristics, clinical characteristics, surgical outcomes, and complications were analyzed. Extent of resection was determined based on volumetric analysis of pre- and postoperative MRI.
Anatomic characteristics that render a tumor difficult to access fully are lateral extension beyond the mid-orbit and anterior extension to the falx. Simpson Grade I resection was achieved in 11/13 (84.6 %) cases. Mean pre-operative tumor volume was 8.99 cm (range 2.19-16.79 cm), and 92 % of tumors were WHO grade I. We demonstrate 2 cases of smell preservation, possible with small unilateral tumors and tumors that are confined to either the anterior or posterior portion of the cribriform plate. The post-operative CSF leak rate was 7.7 %, without prophylactic lumbar CSF drainage. The mortality rate was 7.7 % (n = 1) after infectious complications following CSF leak.
Endoscopic endonasal resection of olfactory groove meningiomas is an effective and safe operative method with outcomes and complication rates comparable to transcranial approaches. Key considerations include careful patient selection and familiarity with technical nuances of endoscopic endonasal approach for this specific tumor type.
尽管经鼻内镜颅底手术(EEA)是一种广泛接受的颅底肿瘤治疗方法,但对于嗅沟脑膜瘤(OGM)的具体应用仍存在争议,文献中报道的结果差异很大。我们回顾了一位外科医生的 OGM 切除术的手术结果,包括手术入路、手术细节和结果,重点关注与患者选择相关的因素,这些因素有利于 EEA 而不是经颅入路。
我们回顾性分析了 13 例经鼻内镜嗅沟脑膜瘤切除术患者的临床资料。分析了患者特征、临床特征、手术结果和并发症。根据术前和术后 MRI 的体积分析来确定切除程度。
使肿瘤难以完全进入的解剖学特征是眶中部外侧延伸和镰状突前部延伸。13 例(84.6%)患者达到 Simpson Ⅰ级切除。术前肿瘤体积平均为 8.99cm³(范围 2.19-16.79cm³),92%的肿瘤为 WHO 分级 I 级。我们展示了 2 例嗅觉保留的病例,可能适用于单侧小肿瘤和局限于筛板前或后部分的肿瘤。术后脑脊液漏发生率为 7.7%,未预防性行腰椎脑脊液引流。因脑脊液漏后感染并发症导致死亡率为 7.7%(n=1)。
经鼻内镜嗅沟脑膜瘤切除术是一种有效且安全的手术方法,其结果和并发症发生率与经颅入路相当。关键考虑因素包括仔细选择患者,以及熟悉针对这种特定肿瘤类型的经鼻内镜入路的技术细节。